[1]ÐܹâÎä*.ÔçÆÚ×Ó¹¬¾±°©±£ÁôÉúÓý¹¦ÄÜÊÖÊõµÄÊõʽѡÔñºÍи¨Öú»¯ÁÆ[J].Öйú΢´´Íâ¿ÆÔÓÖ¾,2021,01(5):385-389.

µã»÷¸´ÖÆ

ÔçÆÚ×Ó¹¬¾±°©±£ÁôÉúÓý¹¦ÄÜÊÖÊõµÄÊõʽѡÔñºÍи¨Öú»¯ÁÆ()

·ÖÏíµ½£º

²Î¿¼ÎÄÏ×/References:

[1]Bentivegna E,Maulard A,Pautier P,et al.Fertility results and pregnancy outcomes after conservative treatment of cervical cancer:a systematic review of the literature.Fertil Steril,2016,106(5):1195-1211.e5.
[2]Pandraklakis A,Thomakos N,Prodromidou A,et al.The conundrum of prematurity and pregnancy outcomes after fertility sparing treatment modalities for early stage cervical cancer:a systematic review of the literature.Folia Med (Plovdiv),2020,62(3):453-461.
[3]Nezhat C,Roman RA,Rambhatla A,et al.Reproductive and oncologic outcomes after fertilityª²sparing surgery for early stage cervical cancer:a systematic review.Fertil Steril,2020,113(4):685-703.
[4]Kuznicki ML,Chambers LM,Morton M,et al.Fertilityª²sparing surgery for earlyª²stage cervical cancer:a systematic review of the literature.J Minim Invasive Gynecol,2020 Oct 24.Online ahead of print.
[5]Zhang Q,Li W,Kanis MJ,et al.Oncologic and obstetrical outcomes with fertilityª²sparing treatment of cervical cancer:a systematic review and metaª²analysis.Oncotarget,2017,8(28):46580-46592.
[6]van Kol KGG,Vergeldt TFM,Bekkers RLM.Abdominal radical trachelectomy versus chemotherapy followed by vaginal radical trachelectomy in stage 1B2 (FIGO 2018) cervical cancer.A systematic review on fertility and recurrence rates.Gynecol Oncol,2019,155(3):515-521.
[7]Rob L,Pluta M,Skapa P,et al.Advances in fertilityª²sparing surgery for cervical cancer.Expert Rev Anticancer Ther,2010,10(7):1101-1114.
[8]Lu Q,Zhang Y,Wang S,et al.Neoadjuvant intraª²arterial chemotherapy followed by total laparoscopic radical trachelectomy in stage IB1 cervical cancer.Fertil Steril,2014,101(3):812-817.
[9]Tesfai FM,Kroep JR,Gaarenstroom K,et al.Fertilityª²sparing surgery of cervical cancer >2 cm (International Federation of Gynecology and Obstetrics 2009 stage IB1-IIA) after neoadjuvant chemotherapy.Int J Gynecol Cancer,2020,30(1):115-121.
[10]Zusterzeel PLM,Aarts JWM,Pol FJM,et al.Neoadjuvant chemotherapy followed by vaginal radical trachelectomy as fertilityª²preserving treatment for patients with FIGO 2018 stage 1B2 cervical cancer.Oncologist,2020,25(7):e1051-e1059.
[11]Robova H,Halaska MJ,Pluta M,et al.Oncological and pregnancy outcomes after highª²dose density neoadjuvant chemotherapy and fertilityª²sparing surgery in cervical cancer.Gynecol Oncol,2014,135(2):213-216.
[12]Salihi R,Leunen K,Van Limbergen E,et al.Neoadjuvant chemotherapy followed by large cone resection as fertilityª²sparing therapy in stage IB cervical cancer.Gynecol Oncol,2015,139(3):447-451.
[13]Rend¨®n GJ,Lopez Blanco A,Aragona A,et al.Oncological and obstetrical outcomes after neoª²adjuvant chemotherapy followed by fertilityª²sparing surgery in patients with cervical cancer 2 cm.Int J Gynecol Cancer,2020 Nov 16.Online ahead of print.
[14]Yan H,Liu Z,Fu X,et al.Longª²term outcomes of radical vaginal trachelectomy and laparoscopic pelvic lymphadenectomy after neoadjuvant chemotherapy for the IB1 cervical cancer:a series of 60 cases.Int J Surg,2016,29:38-42.